Bank of America’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.03K | Buy |
848
+627
| +284% | +$1.5K | ﹤0.01% | 6395 |
|
|
2025
Q1 | $950 | Sell |
221
-249,421
| -100% | -$1.07M | ﹤0.01% | 6381 |
|
|
2024
Q4 | $2.15M | Buy |
249,642
+249,521
| +206,216% | +$2.15M | ﹤0.01% | 3696 |
|
|
2024
Q3 | $2.06K | Buy |
121
+26
| +27% | +$443 | ﹤0.01% | 6197 |
|
|
2024
Q2 | $1.43K | Sell |
95
-342
| -78% | -$5.15K | ﹤0.01% | 6290 |
|
|
2024
Q1 | $7.26K | Sell |
437
-1,961
| -82% | -$32.6K | ﹤0.01% | 6052 |
|
|
2023
Q4 | $38.4K | Sell |
2,398
-1,759
| -42% | -$28.1K | ﹤0.01% | 5731 |
|
|
2023
Q3 | $317K | Buy |
4,157
+3,558
| +594% | +$271K | ﹤0.01% | 4783 |
|
|
2023
Q2 | $39.3K | Buy |
599
+512
| +589% | +$33.6K | ﹤0.01% | 5671 |
|
|
2023
Q1 | $5.17K | Buy |
87
+29
| +50% | +$1.72K | ﹤0.01% | 6238 |
|
|
2022
Q4 | $1.35K | Sell |
58
-1,698
| -97% | -$39.4K | ﹤0.01% | 6473 |
|
|
2022
Q3 | $59K | Sell |
1,756
-492
| -22% | -$16.5K | ﹤0.01% | 5761 |
|
|
2022
Q2 | $60K | Sell |
2,248
-1,840
| -45% | -$49.1K | ﹤0.01% | 5954 |
|
|
2022
Q1 | $121K | Buy |
4,088
+792
| +24% | +$23.4K | ﹤0.01% | 5987 |
|
|
2021
Q4 | $282K | Buy |
3,296
+1,509
| +84% | +$129K | ﹤0.01% | 5491 |
|
|
2021
Q3 | $133K | Buy |
1,787
+1,554
| +667% | +$116K | ﹤0.01% | 5705 |
|
|
2021
Q2 | $22K | Buy |
+233
| New | +$22K | ﹤0.01% | 6292 |
|